Expression of serum miR-326 and miR-501 in endometrial cancer patients and their correlation with postoperative recurrence
10.3760/cma.j.cn115807-20241018-00324
- VernacularTitle:子宫内膜癌患者血清miR-326、miR-501的表达及与术后复发的相关性分析
- Author:
Xia GAO
1
;
Lihua PEI
1
Author Information
1. 长治医学院附属和平医院妇科，长治 046000
- Publication Type:Journal Article
- Keywords:
Endometrial carcinoma;
miR-326;
miR-501;
Postoperative recurrence
- From:
Chinese Journal of Endocrine Surgery
2025;19(3):429-433
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the expression of serum miR-326 and miR-501 in patients with endometrial cancer (EC) and their correlation with postoperative recurrence.Methods:From Sep. 2020 to Sep. 2023, 108 patients diagnosed with EC who received initial treatment in Heping Hospital Affiliated to Changzhi Medical College were as the study group, and another 108 patients with benign endometrial hyperplasia were as the control group. All EC patients were followed up for 1 year after surgery, and were assigned into a recurrence group of 15 cases and a non recurrence group of 93 cases based on the follow-up results. Real-time fluorescence quantitative polymerase chain reaction (qRT-PCR) was applied to determine the expression levels of serum miR-326 and miR-501. Logistic regression was applied to analyze the factors affecting postoperative recurrence in EC patients. The predictive efficacy of serum miR-326 and miR-501 for postoperative recurrence in EC patients was analyzed by establishing receiver operating characteristic (ROC) curves.Results:Compared with the control group, the expression level of serum miR-326 in the study group was prominently lower ( P<0.05), while the expression level of miR-501 was obviously higher ( P<0.05). Compared with the non recurrence group, the expression level of serum miR-326 in the recurrence group was obviously lower ( P<0.05), while the expression level of miR-501 was obviously higher ( P<0.05). The combination of serum miR-326 and miR-501 had the highest AUC in predicting postoperative recurrence in EC patients, which was better than their individual predictions ( Zcombination - miR-326=2.456, P=0.014, Zcombination - miR-501=2.282, P=0.023). Logistic regression analysis revealed that serum miR-326 was a protective factor affecting postoperative recurrence in EC patients ( P<0.05), while miR-501 was a risk factor affecting postoperative recurrence in EC patients ( P<0.05) . Conclusions:The expression level of miR-326 in the serum of EC patients is prominently reduced, while the expression level of miR-501 is obviously increased. The combination of the two can be better used to predict postoperative recurrence in patients.
